Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
|
CN |
|
F
|
FIBI Holdings Ltd
TASE:FIBIH
|
IL |
|
C
|
CAE Inc
NYSE:CAE
|
CA |
|
China Petrochemical Development Corp
TWSE:1314
|
TW |
|
Holcim AG
OTC:HCMLF
|
CH |
|
Nufarm Ltd
ASX:NUF
|
AU |
|
Rail Vikas Nigam Ltd
NSE:RVNL
|
IN |
|
Genel Energy PLC
LSE:GENL
|
UK |
|
Bilcare Ltd
BSE:526853
|
IN |
|
F
|
Fulum Group Holdings Ltd
HKEX:1443
|
HK |
|
B
|
Bio Planet SA
WSE:BIP
|
PL |
|
K
|
Kernex Microsystems (India) Ltd
NSE:KERNEX
|
IN |
|
American Premium Water Corp
OTC:HIPH
|
US |
|
Gemini Group Global Corp
OTC:GMNI
|
US |
|
Basler Kantonalbank
SIX:BSKP
|
CH |
|
B
|
Bank of Nova Scotia
BMV:BNS
|
CA |
|
Creo Medical Group PLC
LSE:CREO
|
UK |
|
BroadBand Security Inc
TSE:4398
|
JP |
|
M
|
Modern Mills Company SJSC
SAU:2284
|
SA |
|
D
|
Doral Group Renewable Energy Resources Ltd
TASE:DORL
|
IL |
Profitability Summary
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
Margins
Earnings Waterfall
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Margins Comparison
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors
| Country | Company | Market Cap |
Gross Margin |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|---|
| CN |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
|
37.4B CNY |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
|
37.4B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
883.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
585.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
237.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
299.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
236.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
